Correlation Between BS Group and Vivoryon Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BS Group and Vivoryon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BS Group and Vivoryon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BS Group SA and Vivoryon Therapeutics NV, you can compare the effects of market volatilities on BS Group and Vivoryon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BS Group with a short position of Vivoryon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BS Group and Vivoryon Therapeutics.

Diversification Opportunities for BS Group and Vivoryon Therapeutics

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BSGR and Vivoryon is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding BS Group SA and Vivoryon Therapeutics NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivoryon Therapeutics and BS Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BS Group SA are associated (or correlated) with Vivoryon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivoryon Therapeutics has no effect on the direction of BS Group i.e., BS Group and Vivoryon Therapeutics go up and down completely randomly.

Pair Corralation between BS Group and Vivoryon Therapeutics

Assuming the 90 days trading horizon BS Group SA is expected to generate 1.63 times more return on investment than Vivoryon Therapeutics. However, BS Group is 1.63 times more volatile than Vivoryon Therapeutics NV. It trades about -0.09 of its potential returns per unit of risk. Vivoryon Therapeutics NV is currently generating about -0.53 per unit of risk. If you would invest  481.00  in BS Group SA on August 27, 2024 and sell it today you would lose (26.00) from holding BS Group SA or give up 5.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BS Group SA  vs.  Vivoryon Therapeutics NV

 Performance 
       Timeline  
BS Group SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BS Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, BS Group is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Vivoryon Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vivoryon Therapeutics NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vivoryon Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

BS Group and Vivoryon Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BS Group and Vivoryon Therapeutics

The main advantage of trading using opposite BS Group and Vivoryon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BS Group position performs unexpectedly, Vivoryon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivoryon Therapeutics will offset losses from the drop in Vivoryon Therapeutics' long position.
The idea behind BS Group SA and Vivoryon Therapeutics NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges